These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18217680)

  • 1. cDNA microarray and bioinformatic analysis of nuclear factor-kappaB related genes in squamous cell carcinoma.
    Chen Z; Lee TL; Yang XP; Dong G; Loercher A; Van Waes C
    Methods Mol Biol; 2007; 383():81-99. PubMed ID: 18217680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
    Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C
    Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
    Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel nuclear factor-kappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status.
    Lee TL; Yang XP; Yan B; Friedman J; Duggal P; Bagain L; Dong G; Yeh NT; Wang J; Zhou J; Elkahloun A; Van Waes C; Chen Z
    Clin Cancer Res; 2007 Oct; 13(19):5680-91. PubMed ID: 17908957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway.
    Dong G; Loukinova E; Chen Z; Gangi L; Chanturita TI; Liu ET; Van Waes C
    Cancer Res; 2001 Jun; 61(12):4797-808. PubMed ID: 11406555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-kappaB and other signal transcription factors in head and neck squamous cell carcinoma.
    Yan B; Yang X; Lee TL; Friedman J; Tang J; Van Waes C; Chen Z
    Genome Biol; 2007; 8(5):R78. PubMed ID: 17498291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma.
    Gaykalova DA; Manola JB; Ozawa H; Zizkova V; Morton K; Bishop JA; Sharma R; Zhang C; Michailidi C; Considine M; Tan M; Fertig EJ; Hennessey PT; Ahn J; Koch WM; Westra WH; Khan Z; Chung CH; Ochs MF; Califano JA
    Int J Cancer; 2015 Oct; 137(8):1879-89. PubMed ID: 25857630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of transcription factor nuclear factor-kappaB by a mutant inhibitor-kappaBalpha attenuates resistance of human head and neck squamous cell carcinoma to TNF-alpha caspase-mediated cell death.
    Duffey DC; Crowl-Bancroft CV; Chen Z; Ondrey FG; Nejad-Sattari M; Dong G; Van Waes C
    Br J Cancer; 2000 Nov; 83(10):1367-74. PubMed ID: 11044363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor-KappaB as a common target and activator of oncogenes in head and neck squamous cell carcinoma.
    Chang AA; Van Waes C
    Adv Otorhinolaryngol; 2005; 62():92-102. PubMed ID: 15608421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems biology-defined NF-kappaB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status.
    Yan B; Chen G; Saigal K; Yang X; Jensen ST; Van Waes C; Stoeckert CJ; Chen Z
    Genome Biol; 2008; 9(3):R53. PubMed ID: 18334025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
    Bancroft CC; Chen Z; Dong G; Sunwoo JB; Yeh N; Park C; Van Waes C
    Clin Cancer Res; 2001 Feb; 7(2):435-42. PubMed ID: 11234901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
    Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
    Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akt Signal Transduction Pathways and Nuclear Factor-kappa B (NF-κB) Transcription as a Molecular Target of Oral Tongue Squamous Cell Carcinoma (SP-C1) Using Papua's Anthill Plant ( Myrmecodia pendans ).
    Achmad H; Supriatno ; Singgih MF; Hendrastuti H
    Pak J Biol Sci; 2016; 19(8-9):323-330. PubMed ID: 29023018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma.
    Kaliyaperumal K; Sharma AK; McDonald DG; Dhindsa JS; Yount C; Singh AK; Won JS; Singh I
    Redox Biol; 2015 Dec; 6():41-50. PubMed ID: 26177470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma.
    Dong G; Chen Z; Kato T; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3495-504. PubMed ID: 10416616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
    Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
    Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.
    Allen CT; Ricker JL; Chen Z; Van Waes C
    Head Neck; 2007 Oct; 29(10):959-71. PubMed ID: 17405170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.
    Van Laere SJ; Van der Auwera I; Van den Eynden GG; Elst HJ; Weyler J; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3249-56. PubMed ID: 16740744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling.
    Aggarwal S; Takada Y; Singh S; Myers JN; Aggarwal BB
    Int J Cancer; 2004 Sep; 111(5):679-92. PubMed ID: 15252836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma.
    Ferris RL; Grandis JR
    Clin Cancer Res; 2007 Oct; 13(19):5663-4. PubMed ID: 17908953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.